// App-Quantinova.ai

2930 : The hostile microenvironment developed in 3D culture conditions induces Trastuzumab resistance involving cancer stem cells

Researchers

Presenter

  • Cristina E. Rodriguez

Principal Investigators

  • Gabriel L. Fiszman

  • Elisa D. Bal de Kier joffe

Medical Centers

  • Inst. of Oncology A. H. Roffo, University of Buenos Aires, Ciudad de Buenos Aires, Argentina.

Locations

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • Trastuzumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved